Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells

Journal of Immunology

Volumn 179, Issue 8, 2007, Pages 5281-5290

  Alvarez Arias, Diana A ^a   Campbell, Kerry S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; PHOSPHOTRANSFERASE; PROTEIN KINASE C; RECEPTOR; SERINE; THREONINE; CASEIN KINASE II; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL FUNCTION; CELL MEMBRANE; CYTOTOXICITY; ENZYME REGULATION; GENE MAPPING; GENE REPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; MUTANT; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; WILD TYPE; AMINO ACID SUBSTITUTION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DOWN REGULATION; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID SUBSTITUTION; CASEIN KINASE II; CELL LINE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; GLUTAMIC ACID; HUMANS; KILLER CELLS, NATURAL; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, KIR; RECEPTORS, KIR3DL1; SERINE; SUBSTRATE SPECIFICITY; THREONINE;

EID: 38449117450     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.8.5281     Document Type: Article

References (56)

1. Kaufman, D. S., R. A. Schoon, and P. J. Leibson. 1993. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. J. Immunol. 150: 1429-1436.
2. Garrido, F., T. Cabrera, M. A. Lopez-Nevot, and F. Ruiz-Cabello. 1995. HLA class I antigens in human tumors. Adv. Cancer Res. 67: 155-195.
3. Biron, C. A. 1997. Natural killer cell regulation during viral infection. Biochem. Soc. Trans. 25: 687-690.
4. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280: 248-253.
5. Storkus, W. J., D. N. Howell, R. D. Salter, J. R. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138: 1657-1659.
6. Leibson, P. J., K. P. Windebank, T. J. Barna, and R. T. Abraham. 1989. Signal transduction mechanisms in human natural killer cells mediating antitumor immunity. Haematol. Blood Transfus. 32: 281-283.
7. Yokoyama, W. M. 1998. Natural killer cell receptors. Curr. Opin. Immunol. 10: 298-305.
8. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180: 537-543.
9. Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. L. Lanier, J. P. Kinet, R. T. Abraham, and P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5: 629-638.
10. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77-85.
11. Bruhns, P., P. Marchetti, W. H. Fridman, E. Vivier, and M. Daeron. 1999. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors. J. Immunol. 162: 3168-3175.
12. Yusa, S., and K. S. Campbell. 2003. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells. J. Immunol. 170: 4539-4547.
13. Yusa, S., T. L. Catina, and K. S. Campbell. 2004. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J. Immunol. 172: 7385-7392.
14. Binstadt, B. A., D. D. Billadeau, D. Jevremovic, B. L. Williams, N. Fang, T. Yi, G. A. Koretzky, R. T. Abraham, and P. J. Leibson. 1998. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J. Biol. Chem. 273: 27518-27523.
15. Stebbins, C. C., C. Watzl, D. D. Billadeau, P. J. Leibson, D. N. Burshtyn, and E. O. Long. 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell Biol. 23: 6291-6299.
16. Valiante, N. M., J. H. Phillips, L. L. Lanier, and P. Parham. 1996. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-γ signaling complex in human natural killer (NK) cells. J. Exp. Med. 184: 2243-2250.
17. Chwae, Y. J., M. J. Chang, S. M. Park, H. Yoon, H. J. Park, S. J. Kim, and J. Kim. 2002. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J. Immunol. 169: 3726-3735.
18. Bioukar, E. B., N. C. Marricco, D. Zuo, and L. Larose. 1999. Serine phosphorylation of the ligand-activated β-platelet-derived growth factor receptor by casein kinase I-γ2 inhibits the receptor's autophosphorylating activity. J. Biol. Chem. 274: 21457-21463.
19. Ritter, M., C. Buechler, M. Kapinsky, and G. Schmitz. 2001. Interaction of CD163 with the regulatory subunit of casein kinase II (CKII) and dependence of CD163 signaling on CKII and protein kinase C. Eur. J. Immunol. 31: 999-1009.
20. Ruzzene, M., A. M. Brunati, S. Sarno, O. Marin, A. Donella-Deana, and L. A. Pinna. 2000. Ser/Thr phosphorylation of hematopoietic specific protein 1 (HS1): implication of protein kinase CK2. Eur. J. Biochem. 267: 3065-3072.
21. Muller, R., J. Wienands, and M. Reth. 2000. The serine and threonine residues in the Ig-α cytoplasmic tail negatively regulate immunoreceptor tyrosine-based activation motif-mediated signal transduction. Proc. Natl. Acad. Sci. USA 97: 8451-8454.
22. Dietrich, J., T. Bäckström, J. P. Lauritsen, J. Kastrup, M. D. Christensen, F. von Bülow, E. Palmer, and C. Geisler. 1998. The phosphorylation state of CD3γ influences T cell responsiveness and controls T cell receptor cycling. J. Biol. Chem. 273: 24232-24238.
23. von Essen, M., M. W. Nielsen, C. M. Bonefeld, L. Boding, J. M. Larsen, M. Leitges, G. Baier, N. Odum, and C. Geisler. 2006. Protein kinase C (PKC) α and PKC θ are the major PKC isotypes involved in TCR down-regulation. J. Immunol. 176: 7502-7510.
24. Hill, B. L., K. Drickamer, F. M. Brodsky, and P. Parham. 1988. Identification of the phosphorylation sites of clathrin light chain LCβ. J. Biol. Chem. 263: 5499-5501.
25. Calvo, J., J. M. Vilda, L. Places, M. Simarro, O. Padilla, D. Andreu, K. S. Campbell, C. Aussel, and F. Lozano. 1998. Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J. Immunol. 161: 6022-6029.
26. Raman, C., and R. P. Kimberly. 1998. Differential CD5-dependent regulation of CD5-associated CK2 activity in mature and immature T cells: implication on TCR/CD3-mediated activation. J. Immunol. 161: 5817-5820.
27. Vila, J. M., J. Calvo, L. Places, O. Padilla, M. Arman, I. Gimferrer, C. Aussel, J. Vives, and F. Lozano. 2001. Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. J. Immunol. 166: 396-402.
28. Luttrell, L. M., and R. J. Lefkowitz. 2002. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115: 455-465.
29. Kim, Y. M., L. S. Barak, M. G. Caron, and J. L. Benovic. 2002. Regulation of arrestin-3 phosphorylation by casein kinase II. J. Biol. Chem. 277: 16837-16846.
30. Yusa, S., T. L. Catina, and K. S. Campbell. 2002. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J. Immunol. 168: 5047-5057.
31. Robinson, J., M. J. Waller, P. Stoehr, and S. G. Marsh. 2005. IPD: the immuno polymorphism database. Nucleic Acids Res. 33: D523-D526.
32. Kloeker, S., R. Reed, J. L. McConnell, D. Chang, K. Tran, R. S. Westphal, B. K. Law, R. J. Colbran, M. Kamoun, K. S. Campbell, and B. E. Wadzinski. 2003. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein. Protein Expr. Purif. 31: 19-33.
33. Cooper, J. A., B. M. Sefton, and T. Hunter. 1983. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 99: 387-402.
34. Kamps, M. P., and B. M. Sefton. 1989. Acid and base hydrolysis of phosphoproteins bound to immobilon facilitates analysis of phosphoamino acids in gelfractionated proteins. Anal. Biochem. 176: 22-27.
35. Dietrich, J., C. Menne, J. P. Lauritsen, M. von Essen, A. B. Rasmussen, N. Odum, and C. Geisler. 2002. Ligand-induced TCR down-regulation is not dependent on constitutive TCR cycling. J. Immunol. 168: 5434-5440.
36. Hou, P., E. Araujo, T. Zhao, M. Zhang, D. Massenburg, M. Veselits, C. Doyle, A. R. Dinner, and M. R. Clark. 2006. B cell antigen receptor signaling and internalization are mutually exclusive events. PLoS Biol. 4: e200.
37. Obenauer, J. C., L. C. Cantley, and M. B. Yaffe. 2003. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 31: 3635-3641.
38. Barclay, J. W., T. J. Craig, R. J. Fisher, L. F. Ciufo, G. J. Evans, A. Morgan, and R. D. Burgoyne. 2003. Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. J. Biol. Chem. 278: 10538-10545.
39. Pitula, J. S., K. M. Deck, S. L. Clarke, S. A. Anderson, A. Vasanthakumar, and R. S. Eisenstein. 2004. Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phosphomimetic mutation of serine-711. Proc. Natl. Acad. Sci. USA 101: 10907-10912.
40. Newton, A. C. 2001. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101: 2353-2364.
41. Rena, G., J. Bain, M. Elliott, and P. Cohen. 2004. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 5: 60-65.
42. Chuang, S. S., J. K. Lee, and P. A. Mathew. 2003. Protein kinase C is involved in 2B4 (CD244)-mediated cytotoxicity and AP-1 activation in natural killer cells. Immunology 109: 432-439.
43. Shenoy, A. M., and Z. Brahmi. 1991. Inhibition of the calpain-mediated proteolysis of protein kinase C enhances lytic activity in human NK cells. Cell Immunol. 138: 24-34.
44. Teng, J. M., X. R. Liu, G. B. Mills, and B. Dupont. 1996. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. J. Immunol. 156: 3222-3232.
45. MacFarlane, A. W., IV, and K. S. Campbell. 2006. Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 298: 23-57.
46. + T cells is controlled by T-cell receptor engagement. Nature 403: 325-328.
47. Oakley, R. H., S. A. Laporte, J. A. Holt, L. S. Barak, and M. G. Caron. 1999. Association of β-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274: 32248-32257.
48. 2-adrenergic receptor resensitization: differential regulation of receptor resensitization in two distinct cell types. J. Biol. Chem. 272: 27005-27014.
49. Jones, M. L., J. D. Craik, J. M. Gibbins, and A. W. Poole. 2004. Regulation of SHP-1 tyrosine phosphatase in human platelets by serine phosphorylation at its C terminus. J. Biol. Chem. 279: 40475-40483.
50. Yoshida, K., and D. Kufe. 2001. Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase Cδ in response to DNA damage. Mol. Pharmacol. 60: 1431-1438.
51. Knippschild, U., A. Gocht, S. Wolff, N. Huber, J. Lohler, and M. Stoter. 2005. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal 17: 675-689.
52. Songyang, Z., K. P. Lu, Y. T. Kwon, L. H. Tsai, O. Filhol, C. Cochet, D. A. Brickey, T. R. Soderling, C. Bartleson, D. J. Graves, et al. 1996. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell Biol. 16: 6486-6493.
53. Greer, S. F., Y. Wang, C. Raman, and L. B. Justement. 2001. CD45 function is regulated by an acidic 19-amino acid insert in domain II that serves as a binding and phosphoacceptor site for casein kinase 2. J. Immunol. 166: 7208-7218.
54. Gomez, T. S., S. D. McCarney, E. Carrizosa, C. M. Labno, E. O. Comiskey, J. C. Nolz, P. Zhu, B. D. Freedman, M. R. Clark, D. J. Rawlings, et al. 2006. HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity 24: 741-752.
55. Doray, B., P. Ghosh, J. Griffith, H. J. Geuze, and S. Kornfeld. 2002. Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. Science 297: 1700-1703.
56. Milne, D. M., P. Looby, and D. W. Meek. 2001. Catalytic activity of protein kinase CK1δ (casein kinase 1δ) is essential for its normal subcellular localization. Exp. Cell Res. 263: 43-54